Form 4: Moderna Director David Rubenstein Reports Stock Transactions
SEC Form 4 Filing
Director David M. Rubenstein reports acquisition and disposal of Moderna common stock and derivative securities.
Summary
- David M. Rubenstein, a director of Moderna, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On April 30, 2025, Rubenstein acquired 677 shares of common stock through the vesting of restricted stock units.
- Rubenstein also disposed of 677 shares of common stock on the same day.
- Additionally, Rubenstein acquired 12,756 stock options with an exercise price of $28.54, expiring on April 30, 2035.
- He also acquired 8,116 restricted stock units that will vest on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to continued service.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral.
Future Outlook
The restricted stock units will vest on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to the market.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 04/30/2025 | Date of transaction: acquisition and disposal of common stock, acquisition of stock options and restricted stock units. |
| 04/30/2026 | Date on which restricted stock units will vest, or Moderna's next Annual Meeting of Shareholders, subject to continued service. |
| 04/30/2035 | Expiration date of the acquired stock options. |
| 05/01/2025 | Date of signature by Attorney-in-Fact. |
Keywords
Form 4, Moderna, Rubenstein, Stock Options, Restricted Stock Units, Beneficial Ownership, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.